
|Videos|June 26, 2020
Clinical Ramifications of Pneumococcal Vaccine Development
Author(s)Contagion® Editorial Staff
Dr. Luwy Musey, executive director in biologics, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Advertisement
Segment Description: Dr. Luwy Musey, executive director in biologics, vaccine clinical research, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Part 1: Developments in Pneumococcal Conjugate Vaccines
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Review of Cefepime and Zidebactam: A Novel Antibiotic Approved to Treat Complicated Urinary Tract Infections
2
Bepirovirsen Phase 3 Results Offer Potential Cure for Chronic Hepatitis B
3
FDA Approves Tebipenem Pivoxil as First Oral Carbapenem For Complicated Urinary Tract Infections
4
FDA Expands Merck Pneumococcal Vaccine Indication to Include At-Risk Children and Adolescents
5






































































































































































